Litigation attorneys are constantly bombarded with news of trial victories and defeats – millions of dollars awarded in damages in one case while a defense verdict is achieved in another. Although some attorneys may read...more
The Tennessee General Assembly enacted legislation in 2021 to update and reform the certificate of need (“CON”) process. The legislative effort to change Tennessee CON law began in the General Assembly’s 2020 session. With...more
In this issue of Pro Te (Volume 11, No.3), we examine three important topics that are sure to capture your interest.
The Supreme Court’s Bristol-Meyers Squibb decision was met with no small amount of (completely justified)...more
12/5/2018
/ Actual Damages ,
Advertising ,
Bristol-Myers Squibb ,
Bristol-Myers Squibb Co v Superior Court of California - San Francisco County ,
Cosmetics ,
Damage Caps ,
FDA Approval ,
Personal Jurisdiction ,
Pharmaceutical Industry ,
Product Labels ,
Wrongful Death
It’s hard to believe a decade has passed since we delivered our first edition of Pro Te: Solutio to your door. Those years have brought enormous changes in the world and in our industry. Innovation has driven everything we...more
7/17/2018
/ 21st Century Cures Act ,
Affordable Care Act ,
Client Services ,
Depositions ,
DQSA ,
Emergency Response ,
Enforcement Actions ,
FDASIA ,
Food and Drug Administration (FDA) ,
Food and Drug Administration Amendments Act (FDAAA) ,
Health Care Providers ,
Health Insurance ,
Hospitals ,
Innovation ,
Juror ,
Jury Trial ,
Law Firm Associates ,
Law Firm Ownership ,
Law Firm Partners ,
Law Practice Management ,
Manufacturers ,
Medical Device User Fee Program (MDUFA IV) ,
Medical Devices ,
Multidistrict Litigation ,
Patient Rights ,
Patient Safety ,
Patients ,
Pharmaceutical Industry ,
Preemption ,
Questionnaires ,
Reporting Requirements ,
State Law Tort Claims ,
Voir Dire ,
Witness Preparation
In This Issue:
- Can Experts Testify as to the Ethics or State of Mind of Corporate Defendants?
- Patent Reform for Biotech Companies
- United States v. Caronia and its Implications for Off-Label...more
5/22/2013
/ America Invents Act ,
Biotechnology ,
Daubert Standards ,
Ethics ,
Expert Testimony ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
First-to-File ,
Food and Drug Administration (FDA) ,
Free Speech ,
Off-Label Use ,
Patent Reform ,
Patents ,
Pharmaceutical Industry ,
Prior Use ,
Testimony